Li‐Chiu Wu

780 total citations
26 papers, 587 citations indexed

About

Li‐Chiu Wu is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Li‐Chiu Wu has authored 26 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Cardiology and Cardiovascular Medicine and 8 papers in Molecular Biology. Recurrent topics in Li‐Chiu Wu's work include Diabetes Treatment and Management (10 papers), Heart Failure Treatment and Management (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Li‐Chiu Wu is often cited by papers focused on Diabetes Treatment and Management (10 papers), Heart Failure Treatment and Management (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Li‐Chiu Wu collaborates with scholars based in Taiwan, United States and South Korea. Li‐Chiu Wu's co-authors include Chia‐Hsuin Chang, Jou‐Wei Lin, Mei‐Shu Lai, Lee‐Ming Chuang, K. Arnold Chan, James L. Caffrey, Jiun‐Ling Wang, Sengwee Toh, Fu‐Chun Chiu and Yaa‐Hui Dong and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Li‐Chiu Wu

24 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Li‐Chiu Wu Taiwan	12	261	202	132	125	119	26	587
Mathieu R. Brodeur Canada	13	193 0.7×	123 0.6×	101 0.8×	71 0.6×	64 0.5×	27	577
Alessandra Scamporrino Italy	15	166 0.6×	197 1.0×	83 0.6×	185 1.5×	31 0.3×	36	583
Horațiu Silaghi Romania	12	116 0.4×	158 0.8×	59 0.4×	141 1.1×	68 0.6×	31	531
Süleyman Hilmi İpekçi Türkiye	15	97 0.4×	128 0.6×	63 0.5×	88 0.7×	78 0.7×	45	487
Maria Donata Di Taranto Italy	18	167 0.6×	103 0.5×	142 1.1×	51 0.4×	43 0.4×	48	751
Antonina Giammanco Italy	13	127 0.5×	113 0.6×	136 1.0×	106 0.8×	25 0.2×	50	482
Chunhua Lin China	11	176 0.7×	87 0.4×	44 0.3×	191 1.5×	63 0.5×	33	491
Fabian Kütting Germany	10	104 0.4×	178 0.9×	82 0.6×	394 3.2×	115 1.0×	26	728
Soichiro Saikawa Japan	13	228 0.9×	127 0.6×	32 0.2×	245 2.0×	90 0.8×	26	593
Viera Kupčová Slovakia	11	242 0.9×	233 1.2×	27 0.2×	208 1.7×	29 0.2×	36	635

Countries citing papers authored by Li‐Chiu Wu

Since Specialization

Citations

This map shows the geographic impact of Li‐Chiu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Chiu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Chiu Wu more than expected).

Fields of papers citing papers by Li‐Chiu Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐Chiu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Chiu Wu. The network helps show where Li‐Chiu Wu may publish in the future.

Co-authorship network of co-authors of Li‐Chiu Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Chiu Wu. A scholar is included among the top collaborators of Li‐Chiu Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Chiu Wu. Li‐Chiu Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chang, Chia‐Hsuin, et al.. (2025). Continuation Versus Discontinuation of Sodium‐Glucose Cotransporter‐2 Inhibitors and Cardiorenal Outcomes Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A Nationwide Cohort Study With a Target Trial Emulation Framework. Clinical and Translational Science. 18(8). e70319–e70319. 1 indexed citations

Chang, Tien‐Jyun, et al.. (2024). Albuminuria‐based stratification of end‐stage kidney disease progression and mortality with sodium‐glucose cotransporter 2 inhibitors (SGLT2i): A retrospective cohort study in type 2 diabetes and chronic kidney disease. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 44(11). 828–840.

Liu, Yulun, Chia‐Hsuin Chang, Li‐Chiu Wu, et al.. (2023). Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination—A nationwide study. Journal of Microbiology Immunology and Infection. 56(3). 558–565. 8 indexed citations

Dong, Yaa‐Hui, Jo‐Hsuan Wu, Chia‐Hsuin Chang, et al.. (2022). Association between glucagon‐like peptide‐1 receptor agonists and biliary‐related diseases in patients with type 2 diabetes: A nationwide cohort study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 42(6). 483–494. 13 indexed citations

Lee, Yen‐Chieh, et al.. (2022). Risk of major adverse limb events in patients with type 2 diabetes mellitus receiving sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A population-based retrospective cohort study. Frontiers in Pharmacology. 13. 869804–869804. 3 indexed citations

Wu, Cho‐Kai, Jou‐Wei Lin, Li‐Chiu Wu, & Chia‐Hsuin Chang. (2019). Risk of Heart Failure Hospitalization Associated With Cilostazol in Diabetes: A Nationwide Case–Crossover Study. Frontiers in Pharmacology. 9. 1467–1467. 12 indexed citations

Chang, Chia‐Hsuin, Jiun‐Ling Wang, Li‐Chiu Wu, Lee‐Ming Chuang, & Hsien-Ho Lin. (2018). Diabetes, Glycemic Control, and Risk of Infection Morbidity and Mortality: A Cohort Study. SSRN Electronic Journal.

Wang, Jiun‐Ling, Yaa‐Hui Dong, Wen‐Chien Ko, et al.. (2018). Thiazolidinediones and reduced risk of incident bacterial abscess in adults with type 2 diabetes: A population‐based cohort study. Diabetes Obesity and Metabolism. 20(12). 2811–2820. 1 indexed citations

Chang, Chia‐Hsuin, Yi‐Cheng Chang, Jou‐Wei Lin, et al.. (2016). No increased risk of hospitalization for heart failure for patients treated with dipeptidyl peptidase-4 inhibitors in Taiwan. International Journal of Cardiology. 220. 14–20. 17 indexed citations

10.

Chang, Chia‐Hsuin, et al.. (2016). Stent revascularization versus bypass surgery for peripheral artery disease in type 2 diabetic patients – an instrumental variable analysis. Scientific Reports. 6(1). 37177–37177. 9 indexed citations

11.

Chang, Chia‐Hsuin, Chien‐Hsieh Chiang, Chung‐Jen Yen, et al.. (2016). Antihypertensive agents and the risk of breast cancer in women aged 55 years and older. Journal of Hypertension. 34(3). 558–566. 20 indexed citations

12.

Chang, Chia‐Hsuin, Jou‐Wei Lin, Sheng‐Yuan Ruan, et al.. (2014). Comparing individual angiotensin-converting enzyme inhibitors with losartan in the risk of hospitalization for pneumonia and related mortality. Journal of Hypertension. 33(3). 634–643. 5 indexed citations

13.

Chang, Chia‐Hsuin, Yi‐Cheng Chang, Li‐Chiu Wu, et al.. (2014). Different angiotensin receptor blockers and incidence of diabetes: a nationwide population-based cohort study. Cardiovascular Diabetology. 13(1). 91–91. 11 indexed citations

14.

Wang, Jiun‐Ling, Chia‐Hsuin Chang, Jou‐Wei Lin, et al.. (2014). Infection, antibiotic therapy and risk of colorectal cancer: A nationwide nested case–control study in patients with Type 2 diabetes mellitus. International Journal of Cancer. 135(4). 956–967. 58 indexed citations

15.

Lin, Jou‐Wei, Chia‐Hsuin Chang, James L. Caffrey, Li‐Chiu Wu, & Mei‐Shu Lai. (2014). Examining the Association of Olmesartan and Other Angiotensin Receptor Blockers With Overall and Cause-Specific Mortality. Hypertension. 63(5). 968–976. 7 indexed citations

16.

Chang, Chia‐Hsuin, et al.. (2013). National Antiviral Treatment Program and the Incidence of Hepatocellular Carcinoma and Associated Mortality in Taiwan. Medical Care. 51(10). 908–913. 14 indexed citations

17.

Hsu, Chia‐Lin, Chia‐Hsuin Chang, Jou‐Wei Lin, et al.. (2013). Histamine‐2 receptor antagonists and risk of lung cancer in diabetic patients – an exploratory analysis. Pharmacoepidemiology and Drug Safety. 22(6). 632–640. 5 indexed citations

18.

Chang, Chia‐Hsuin, Jou‐Wei Lin, Li‐Chiu Wu, Mei‐Shu Lai, & Lee‐Ming Chuang. (2012). Oral Insulin Secretagogues, Insulin, and Cancer Risk in Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism. 97(7). E1170–E1175. 102 indexed citations

19.

Chang, Chia‐Hsuin, Jou‐Wei Lin, Li‐Chiu Wu, et al.. (2011). Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus. Hepatology. 55(5). 1462–1472. 157 indexed citations

20.

Chang, Chia‐Hsuin, Jou‐Wei Lin, Li‐Chiu Wu, & Mei‐Shu Lai. (2011). Angiotensin Receptor Blockade and Risk of Cancer in Type 2 Diabetes Mellitus: A Nationwide Case-Control Study. Journal of Clinical Oncology. 29(22). 3001–3007. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact